Clinical Trial Update: Trial of Tolerability, Reactogenicity, Safety and Immunogenicity of Flu-M [Inactivated Split Influenza Vaccine] in Pregnant Women [Phase 3]

View source ↗

Summary

Phase 3 trial assessing tolerability, reactogenicity, safety, and immunogenicity of Flu-M in pregnant women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza in Pregnancy

Drugs mentioned

• Flu-M

Snippet

Sponsor: St. Petersburg Research Institute of Vaccines and Sera | Conditions: Influenza, Human, Vaccination; Infection | Phase 3 | Status: COMPLETED